Covid trials on hold

COVID-19 vaccine trials were stopped globally after a recipient in U.K. showed adverse symptoms

The Serum Institute of India (SII) in Pune on Thursday paused the clinical trial of the COVID-19 vaccine candidate being developed by Oxford University’s Jenner Institute and Astra Zeneca following a notice from the Drug Controller General of India (DCGI) on Wednesday.

Even as Oxford University’s vaccine candidate, AZD1222, one of the most promising ones in the race hit a pause after safety concerns, Indian authorities raised hopes that all is not lost. India’s homegrown vaccine candidate, Covaxin, which is currently in its second phase of testing will most probably be cleared for public use in the early months of 2021, according to a leading doctor from All India Institute of Medical Sciences, New Delhi.

Leave a Reply

Your email address will not be published.